About Contact Us Careers
Sign In

IV Disinfecting Caps Market Size & Share, by Product Type (Single Cap, Double Cap); Application (Blood Transfusion, Blood Collection, Infusion); End-user (Hospitals, Clinics, Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4101
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the IV Disinfecting Caps Landscape

top-features-companies
    • Human Metabolome Technologies America Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.    
    • Bio-Rad Laboratories, Inc.
    • Biocrates life sciences AG
    • Agilent Technologies, Inc.                       
    • Merit Medical Systems
    • B. Braun Melsungen AG
    • ICU Medical, Inc.
    • Becton, Dickinson and Company
    • 3M Company
Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fisher Scientific Inc. introduced TrueMark Infectious Disease Research Panels to identify and classify bacteria that cause gastrointestinal, respiratory, vaginal, urinary, and sexually transmitted diseases quickly and accurately. Further, researchers can choose from more than 90 different bacterial and viral strain assays using the predefined and programmable panel options.

  • Biocrates life sciences AG a global leader in targeted metabolomics, acquired Metanomics Health GmbH to offer focused metabolomics profiling services, personalized assays, targeted screening kits, and in-depth data interpretation.

 

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4101
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing health awareness and the rising geriatric population are the major factors driving the market growth.

The market size of IV disinfecting caps is anticipated to attain a CAGR of ~10% over the forecast period, i.e., 2023-2035.

Lack of knowledge regarding the use of disinfectant caps in developing countries and the risk of not securing the sterile cap are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Human Metabolome Technologies America Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Agilent Technologies, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-use, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying